Characterization of circulating CD8+T cells expressing skin homing and cytotoxic molecules in active non-segmental vitiligo

2013 ◽  
Vol 23 (3) ◽  
pp. 331-338 ◽  
Author(s):  
Bao-Xiang Zhang ◽  
Mao Lin ◽  
Xiao-Yi Qi ◽  
Ron-Xin Zhang ◽  
Zhen-Dong Wei ◽  
...  
2009 ◽  
Vol 221 (03) ◽  
Author(s):  
S Pirson ◽  
U Thiel ◽  
H Bernhard ◽  
GHS Richter ◽  
S Burdach

Immunology ◽  
2015 ◽  
Vol 146 (1) ◽  
pp. 50-58 ◽  
Author(s):  
Jiaoyan Lv ◽  
Linlin Zou ◽  
Lina Zhao ◽  
Wei Yang ◽  
Yingluo Xiong ◽  
...  

2008 ◽  
Vol 20 (8) ◽  
pp. 1087-1096 ◽  
Author(s):  
V. Voelter ◽  
N. Rufer ◽  
S. Reynard ◽  
G. Greub ◽  
R. Brookes ◽  
...  

2020 ◽  
Vol 117 (12) ◽  
pp. 6686-6696 ◽  
Author(s):  
Benoît P. Nicolet ◽  
Aurélie Guislain ◽  
Floris P. J. van Alphen ◽  
Raquel Gomez-Eerland ◽  
Ton N. M. Schumacher ◽  
...  

Cytotoxic CD8+T cells can effectively kill target cells by producing cytokines, chemokines, and granzymes. Expression of these effector molecules is however highly divergent, and tools that identify and preselect CD8+T cells with a cytotoxic expression profile are lacking. Human CD8+T cells can be divided into IFN-γ– and IL-2–producing cells. Unbiased transcriptomics and proteomics analysis on cytokine-producing fixed CD8+T cells revealed that IL-2+cells produce helper cytokines, and that IFN-γ+cells produce cytotoxic molecules. IFN-γ+T cells expressed the surface marker CD29 already prior to stimulation. CD29 also marked T cells with cytotoxic gene expression from different tissues in single-cell RNA-sequencing data. Notably, CD29+T cells maintained the cytotoxic phenotype during cell culture, suggesting a stable phenotype. Preselecting CD29-expressing MART1 TCR-engineered T cells potentiated the killing of target cells. We therefore propose that CD29 expression can help evaluate and select for potent therapeutic T cell products.


2013 ◽  
Vol 87 (18) ◽  
pp. 10263-10272 ◽  
Author(s):  
M. C. van Aalderen ◽  
E. B. M. Remmerswaal ◽  
K. M. Heutinck ◽  
A. ten Brinke ◽  
H. Pircher ◽  
...  

2017 ◽  
Vol 91 (19) ◽  
Author(s):  
Michael T. Hensel ◽  
Tao Peng ◽  
Anqi Cheng ◽  
Stephen C. De Rosa ◽  
Anna Wald ◽  
...  

ABSTRACT Herpes simplex virus (HSV) infection is restricted to epithelial cells and neurons and is controlled by CD8 T cells. These cells both traffic to epithelial sites of recurrent lytic infection and to ganglia and persist at the dermal-epidermal junction for up to 12 weeks after lesion resolution. We previously showed that cutaneous lymphocyte-associated antigen (CLA), a functional E-selectin ligand (ESL), is selectively expressed on circulating HSV-2-specific CD8 T cells. CLA/ESL mediates adhesion of T cells to inflamed vascular endothelium. Later stages in T-cell homing involve chemokines (Ch) and lymphocyte chemokine receptors (ChR) for vascular wall arrest and diapedesis. Several candidate ChR have been implicated in skin homing. We measured cell surface ChR on HSV-specific human peripheral blood CD8 T cells and extended our studies to HSV-1. We observed preferential cell surface expression of CCR10 and CXCR3 by HSV-specific CD8 T cells compared to CD8 T cells specific for control viruses, Epstein-Barr virus (EBV) and cytomegalovirus (CMV), and compared to bulk memory CD8 T cells. CXCR3 ligand mRNA levels were selectively increased in skin biopsy specimens from persons with recurrent HSV-2, while the mRNA levels of the CCR10 ligand CCL27 were equivalent in lesion and control skin. Our data are consistent with a model in which CCL27 drives baseline recruitment of HSV-specific CD8 T cells expressing CCR10, while interferon-responsive CXCR3 ligands recruit additional cells in response to virus-driven inflammation. IMPORTANCE HSV-2 causes very localized recurrent infections in the skin and genital mucosa. Virus-specific CD8 T cells home to the site of recurrent infection and participate in viral clearance. The exit of T cells from the blood involves the use of chemokine receptors on the T-cell surface and chemokines that are present in infected tissue. In this study, circulating HSV-2-specific CD8 T cells were identified using specific fluorescent tetramer reagents, and their expression of several candidate skin-homing-associated chemokine receptors was measured using flow cytometry. We found that two chemokine receptors, CXCR3 and CCR10, are upregulated on HSV-specific CD8 T cells in blood. The chemokines corresponding to these receptors are also expressed in infected tissues. Vaccine strategies to prime CD8 T cells to home to HSV lesions should elicit these chemokine receptors if possible to increase the homing of vaccine-primed cells to sites of infection.


2014 ◽  
Vol 4 (S3) ◽  
Author(s):  
Seung-Hyun Kim ◽  
Katy Saide ◽  
Ye Yuan ◽  
Ann Daly ◽  
Ana Alfirevic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document